A Unique Opportunity to Own a Piece of Medicinal Organic Cannabis Australia (MOCA)
A Unique Opportunity to Own a Piece of Medicinal Organic Cannabis Australia (MOCA)
Medicinal Organic Cannabis Australia (MOCA) is an Australian Government licensed medical cannabis importer, exporter and wholesaler. https://www.medicinalorganiccannabis.org
Our licences allow us to manufacture, import and wholesale medical cannabis products.
In conjunction with international standards, MOCA has developed proprietary production and manufacturing protocols and procedures.
These operational methods of operation are approved at State and Federal level by the New South Wales Ministry of Health and the Office of Drug Control (ODC).
In September 2020, the Therapeutic Goods Administration (TGA) announced an interim decision to reclassify cannabidiol (CBD) products so they can be purchased over-the-counter at pharmacies.
This works very much to MOCA’s advantage.
We have 4 products in our approved range that meet this new rescheduling criteria and that we can supply directly to pharmacists. We view this as an excellent opportunity to sell significant quantities of our products into our partner pharmacies before the end of the year.
The Company works on tight operation overheads and daily running costs and is very agile and responsive to changes in markets and legislation.
Selling our products to medical professionals requires that we build a Sales team on the ground in Australia that can promote and sell our products.
MOCA’s primary objective is to become a leader in the Australian medical cannabis market.
Our focus is on reducing patient access costs for medical cannabis products. We aim to educate medical practitioners, pharmacies and consumer markets on the health benefits of our products.
This expansion into the supply market could allow MOCA to realise substantial sales growth over the next three years with the aim to:
• Increase sales revenue and profitability.
• Increase client base by increasing exposure to national markets
• Generate profits in the 2020/2021 financial years and increase profitability every year over the next 3 years.
• Aim to prepare the Company for a potential float on a relevant Stock Exchange in 2023.
We consider the ‘Triple Bottom line’ (People, Planet, Profit) the ethical measure of business. MOCA’s investment principle determines the impact on the environment, the social perspective, and our corporate governance.
It is for this reason that we influence and control the entire process from soil preparation to genetic selection to cultivation and harvest to manufacturing and wholesale.
Reasons we believe we will succeed.
1. We have all the necessary licences, import permits and TGA approvals in hand. All lights are green to go.
2. We have one of the largest approved ranges of products in Australia, ready for prescription and over the counter sales.
3. Our supply agreements with our manufacturer are locked in place and our product range is ready for import.
4. In Australia we have supply agreements in place with pharmacies and doctors to purchase our products.
5. Our database of medical professionals is primed and ready to direct market with our approved products
6. Our new whole plant infusion will dramatically decrease the cost to consumers and disrupt the industry.
7. MOCA is the only company in Australia with a full range of whole plant organic medical cannabis products.
8. Our logistics model allows MOCA to move products without proprietary warehousing facilities and staff, thus saving on major operational expenses.
9. MOCA is able to fulfil prescriptions online via our partner pharmacies that conveniently ship medication via courier directly to patient’s homes.
10. MOCA’s logistics solution with a global leader in pharmaceutical distribution ensures the Company will meet its scalability requirements (moving from individual product sales to cartons and then pallets) as Australia’s legal cannabis market blooms to an estimated $1.5 billion by 2025.
11. Strategic partnerships are central to our Company’s approach to business. MOCA has signed an ongoing agreement with the leading cultivator and supplier of organic medical (and recreational) cannabis OrganicMarijuana.com
12. We have a cultivation greenhouse in Sardinia ready for 2021 cultivation so that we control the cultivation of plant biomass.
13. MOCA’s Managing Director has over 20 years experience in digital marketing and is completing his PhD on consumer behaviour. The Company currently has over 35,000 unique visitors to its Internet presences each month providing high consumer visibility in a competitive emerging market.